News
LH
238.56
-0.09%
-0.21
Mayar Capital Q4 2024 Letter To Partners
Seeking Alpha · 1h ago
Evercore ISI Remains a Hold on Laboratory Corporation of America Holdings (LH)
TipRanks · 2d ago
Merit Medical Stock Gains Following Solid Preliminary Q4 Revenues
NASDAQ · 2d ago
Laboratory Corporation Of America To Present At J.P. Morgan Conference; Webcast At 6:45 PM ET
NASDAQ · 3d ago
Weekly Report: what happened at LH last week (0106-0110)?
Weekly Report · 4d ago
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Simply Wall St · 5d ago
Labcorp to Participate in J.P. Morgan Healthcare Conference
TipRanks · 01/10 21:51
Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
PR Newswire · 01/10 21:15
Daily Dividend Report: DUK, PAYX, JEF, LH, UNM
NASDAQ · 01/10 14:20
Labcorp Declares Quarterly Cash Dividend for 2025
TipRanks · 01/10 12:33
Why Labcorp (LH) is Poised to Beat Earnings Estimates Again
NASDAQ · 01/09 17:10
Labcorp Holdings declares $0.72 dividend
Seeking Alpha · 01/09 05:19
Press Release: LABCORP DECLARES QUARTERLY DIVIDEND
Dow Jones · 01/08 23:02
LABCORP DECLARES QUARTERLY DIVIDEND
PR Newswire · 01/08 23:02
Labcorp to Announce Q4 2024 Financial Results
TipRanks · 01/08 21:55
Beyond The Numbers: 8 Analysts Discuss Labcorp Holdings Stock
Benzinga · 01/07 22:00
Laboratory Corp. Raised to Outperform From In-Line by Evercore ISI Group
Dow Jones · 01/07 16:16
Laboratory Corp. Price Target Raised to $265.00/Share From $260.00 by Evercore ISI Group
Dow Jones · 01/07 16:16
Evercore ISI Group Upgrades Labcorp Holdings to Outperform, Raises Price Target to $265
Benzinga · 01/07 16:05
Stocks Retreat as Bond Yields Jump
Barchart · 01/07 15:36
More
Webull provides a variety of real-time LH stock news. You can receive the latest news about Labcorp Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About LH
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.